90 research outputs found

    Saints in Space and the Queer Fantastic

    Get PDF
    The following thesis is a creative work focused around saints, space, and whales. The work is comprised of both fiction and creative non-fiction pieces, introduced by a critical-creative preface which examined the intellectual background of the work as well as the authorā€™s creative process. The pieces within cover subject matter pertaining to wonderment, the fantastic, and whales in space. They pay particular attention to relationships between queer women, to the imaginative possibilities of outer-space and the ocean, and mapping the way to a hopeful futur

    The Use of Disposable Chlorhexidine Wipes Compared to Traditional Bed Bath

    Get PDF
    https://scholarworks.moreheadstate.edu/student_scholarship_posters/1218/thumbnail.jp

    Acetone ingestion mimics a fasting state to improve glucose tolerance in a mouse model of gestational hyperglycemia

    Get PDF
    Gestational diabetes mellitus results, in part, from a subā€optimal Ī²ā€cell mass (BCM) during pregnancy. Artemisinins were reported to increase BCM in models of diabetes by Ī±ā€ to Ī²ā€cell conversion leading to enhanced glucose tolerance. We used a mouse model of gestational glucose intolerance to compare the effects of an artemisinin (artesunate) on glycemia of pregnant mice with vehicle treatment (acetone) or no treatment. Animals were treated daily from gestational days (GD) 0.5 to 6.5. An intraperitoneal glucose tolerance test was performed prior to euthanasia at GD18.5 or postā€partum. Glucose tolerance was significantly improved in both pregnant and nonā€pregnant mice with both artesunate and vehicleā€alone treatment, suggesting the outcome was primarily due to the acetone vehicle. In nonā€pregnant, acetoneā€treated animals, improved glucose tolerance was associated with a higher BCM and a significant increase in bihormonal insulin and glucagonā€con-taining pancreatic islet cells, suggesting Ī±ā€ to Ī²ā€cell conversion. BCM did not differ with treatment during pregnancy or postā€partum. However, placental weight was higher in acetoneā€treated animals and was associated with an upregulation of apelinergic genes. Acetoneā€treated animals had reduced weight gain during treatment despite comparable food consumption to nonā€treated mice, suggesting transient effects on nutrient uptake. The mean duodenal and ileum villus height was reduced following exposure to acetone. We conclude that acetone treatment may mimic transient fasting, resulting in a subsequent improvement in glucose tolerance during pregnancy

    To what extent can we rely on the views of family members and friends when it comes to understanding aphasic peopleā€™s quality of life?

    Get PDF
    This study addresses the important question of to what extent can we rely on the views of proxy respondents when it comes to understanding aphasic peopleā€™s quality of life. Thirty proxies answered six open-ended questions on their partnersā€™ behalf in semi-structured interviews. Case by case matches of proxiesā€™ with their aphasic partnersā€™ responses are reported. Proxies were limited in their capacity as informants, able to describe the impact of people, activities, and verbal communication only. Whilst these were the key concepts for aphasic participants, only one third of proxies generally identified them, and the breadth of participantsā€™ views remained uncaptured by proxies (e.g. mobility, oneā€™s home, support from others, positive outlook, in/dependence, health, impairments, and recognising strengths in communication). (119 words

    Level of Agreement of 36-Month ASQ-3 between Parents, Child Care Providers, and Health Care Professionals

    Get PDF
    Introduction Developmental delay is present in approximately 15 percent of children in the United States. 1 Less than one fifth of those children receive early intervention before age 3. Screening processes in pediatric settings are insufficient to identify all children with developmental delay. Objective Investigate the level of agreement in typical methods of administration of the 36 month Ages and Stages Questionnaire 3rd ed. (ASQ 3) between parents, CCPs, and student physical therapists (SPTs). Participants 11 children and parents from 2 childcare centers 5 childcare providers (CCPs) 7 student physical therapists (SPTs) Methods Outcome Measure: 36-Month ASQ-3 Standardized developmental screening tool designed to test a wide age range and be administered by various parties Rapid, simple, and cost effective way to monitor a childā€™s development Developmental screening was conducted across two testing sessions for each child based on common practices of ASQ-3 administration (Fig. 1). Session 1: Parent scored childā€™s performance from memory, unless confronted with novel items in which scoring was inferred or administered. SPT was present for questions. Session 2: CCP administered every item and scored the child based on their elicited performance while another SPT scored as an observer. Results Inter-rater Agreement: CCPs and SPTs significantly agreed in 4/5 domains No significant agreement between parents/CCPs or parents/SPTs for any domain (Table 1). Trends in specific domains (Fig. 2): Highly variable across the 5 domains Gross Motor: 73% of parents scored their childā€™s ability higher than at least one rater from the standardized session by as much as 25 points. Problem Solving: 64% of the parents scored their child as much as 30 points lower than at least one other rater. Conclusion Inter rater agreement between parents and CCPs or healthcare professionals was limited. Clinical Relevance Testing condition for parents was not parallel to the condition for other groups Recommend future exploration into interpretation of this screening tool and best use of the ASQ 3 by parents and CCPs to promote their participation

    UNC2025, a MERTK Small-Molecule Inhibitor, Is Therapeutically Effective Alone and in Combination with Methotrexate in Leukemia Models

    Get PDF
    MERTK tyrosine kinase is ectopically expressed in 30ā€“50% of acute lymphoblastic leukemias (ALL) and over 80% of acute myeloid leukemias (AML) and is a potential therapeutic target. Here, we evaluated the utility of UNC2025, a MERTK tyrosine kinase inhibitor, for treatment of acute leukemia
    • ā€¦
    corecore